Starboard Value LP Elanco Animal Health Inc Transaction History

Starboard Value LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$19.63 - $26.62 $22.9 Million - $31.1 Million	-1,168,980 Reduced 16.94%	5,731,575 $113 Million
Q1 2022 May 13, 2022	SELL	$24.65 - $29.0 $19.4 Million - $22.8 Million	-785,000 Reduced 10.21%	6,900,555 $180 Million
Q4 2021 Feb 14, 2022	BUY	$27.74 - $34.09 $10.4 Million - $12.7 Million	373,843 Added 5.11%	7,685,555 $218 Million
Q3 2021 Nov 12, 2021	SELL	$29.2 - $36.72 $8.61 Million - $10.8 Million	-295,000 Reduced 3.88%	7,311,712 $233 Million
Q2 2021 Aug 13, 2021	SELL	$28.76 - $35.98 $6.44 Million - $8.06 Million	-223,965 Reduced 2.86%	7,606,712 $264 Million
Q1 2021 May 14, 2021	BUY	$27.85 - $34.49 $218 Million - $270 Million	7,830,677 New	7,830,677 $231 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Starboard Value LP, based on Form 13F filings with the SEC.

Stay updated on Starboard Value LP with notifications on news.